(2,2-二甲基-四氢-吡喃-4-基)-甲胺 | 90226-98-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧烷类
• 中文名称: (2,2-二甲基-四氢-吡喃-4-基)-甲胺
• 英文名称: N,2,2-trimethyloxan-4-amine
• 英文别名: 4-Methylamino-2.2-dimethyl-tetrahydropyran；N,2,2-trimethyltetrahydro-2H-pyran-4-amine；(2,2-dimethyl-tetrahydro-pyran-4-yl)-methyl-amine
• CAS: 90226-98-5
• 化学式: C₈H₁₇NO
• mdl: MFCD09749780
• 分子量: 143.229
• InChiKey: RQZSZVXPVMGSAB-UHFFFAOYSA-N

物化性质

• 沸点：
  185.8±33.0 °C(Predicted)
• 密度：
  0.91±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  21.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2932999099

反应信息

• 作为反应物：
  描述：

  (2,2-二甲基-四氢-吡喃-4-基)-甲胺 在 sodium tetrahydroborate 、 lithium aluminium tetrahydride 作用下， 以 甲醇 、 乙醚 、 乙醇 、 苯 为溶剂， 反应 78.0h， 生成 N1-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-N3-(4-methoxybenzyl)-N1-methylpropane-1,3-diamine
  参考文献：
  名称：

  Synthesis and some transformations of N,2,2-trimethyltetrahydro-2H-pyran-4-amine

  摘要：

  Reaction of 2,2-dimethyltetrahydro-2H-pyran-4-one with aqueous methanamine, followed by reduction of the Schiff base thus obtained with sodium tetrahydridoborate gave N,2,2-trimethyltetrahydro-2H-pyran-4-amine which was subjected to cyanoethylation with acrylonitrile. The resulting 3-(2,2-dimethyltetrahydro-2H-pyran-4-ylmethylamino)propanenitrile was reduced with lithium tetrahydridoaluminate to N-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-N-methylpropane-1,3-diamine, and some chemical transformations of the latter were studied.

  DOI：

  10.1134/s1070428012010137
• 作为产物：
  描述：

  四氢-2 2-二甲基-4H-吡喃-4-酮 在 sodium tetrahydroborate 作用下， 以 甲醇 、 水 为溶剂， 生成 (2,2-二甲基-四氢-吡喃-4-基)-甲胺
  参考文献：
  名称：

  Synthesis and some transformations of N,2,2-trimethyltetrahydro-2H-pyran-4-amine

  摘要：

  Reaction of 2,2-dimethyltetrahydro-2H-pyran-4-one with aqueous methanamine, followed by reduction of the Schiff base thus obtained with sodium tetrahydridoborate gave N,2,2-trimethyltetrahydro-2H-pyran-4-amine which was subjected to cyanoethylation with acrylonitrile. The resulting 3-(2,2-dimethyltetrahydro-2H-pyran-4-ylmethylamino)propanenitrile was reduced with lithium tetrahydridoaluminate to N-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-N-methylpropane-1,3-diamine, and some chemical transformations of the latter were studied.

  DOI：

  10.1134/s1070428012010137

文献信息

• [EN] 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES<br/>[FR] DÉRIVÉS DE 2-AMINO-INDOLE 3-SUBSTITUÉS
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2015198045A1

  公开（公告）日：2015-12-30

  The present invention provides compounds of formula (I) (Formula (I)) and pharmaceutically acceptable salts thereof, wherein Q, X% X4,X5 X6, X7,R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.

  本发明提供了公式(I)（公式(I)）的化合物及其药用可接受的盐，其中Q，X，X4，X5，X6，X7，R1，R2，R3和R8如说明书中所定义，这些化合物的制备方法，包含它们的药物组合物以及这些化合物在治疗中的用途。
• SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS
  申请人：Syngenta Crop Protection AG

  公开号：US20200315174A1

  公开（公告）日：2020-10-08

  The invention relates to substituted thiophenyl uracils of general formula (I) or the salts (I) thereof, wherein the groups in general formula (I) are as defined in the description, and to the use thereof as herbicides, in particular for controlling weeds and/or weed grasses in crops of cultivated plants and/or as plant growth regulators for influencing the growth of crops of cultivated plants.

  本发明涉及取代噻吩基尿嘧啶的通式(I)或其盐(I)，其中通式(I)中的基团如描述中定义，以及作为除草剂，特别是用于控制作物中的杂草和/或杂草草本的用途，以及作为植物生长调节剂用于影响栽培植物作物的生长。
• [EN] 1,3-SUBSTITUTED 2-AMINOINDOLE DERIVATIVES AND ANALOGUES USEFUL IN THE TREATMENT OR PREVENTION OF DIABETES MELLITUS, OBESITY AND INFLAMMATORY BOWEL DISEASE<br/>[FR] DÉRIVÉS DE 1,3-SUBSTITUÉS 2-AMINOINDOLES ET ANALOGUES UTILES DANS LE TRAITEMENT OU LA PRÉVENTION DU DIABÈTE SUCRÉ, DE L'OBÉSITÉ ET DE LA MALADIE INTESTINALE INFLAMMATOIRE
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2015198046A1

  公开（公告）日：2015-12-30

  The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein Q, X4, X5, X6, X7, R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.

  本发明提供了式（I）化合物及其药学上可接受的盐，其中Q、X4、X5、X6、X7、R1、R2、R3和R8如规范中所定义，制备这种化合物的方法，含有它们的药物组合物以及这种化合物在治疗中的用途。
• HETEROARYL DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT
  申请人：Voronoi Inc.

  公开号：EP3915986A1

  公开（公告）日：2021-12-01

  The present invention relates to a heteroaryl derivative and a pharmaceutical composition for the prevention or treatment of cancer comprising the same as an active ingredient, and a compound according to an aspect of the present invention, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof suppresses kinases, particularly, a TTK kinase, and thus can remarkably suppress the proliferation of cancer cells, and accordingly, can be effectively used as a pharmaceutical composition for the prevention or treatment of cancer.

  本发明涉及一种杂环芳基衍生物和一种包含其作为活性成分的用于预防或治疗癌症的药物组合物，以及根据本发明的一个方面的化合物，其立体异构体，其水合物或其药用可接受的盐抑制激酶，特别是TTK激酶，因此可以显著抑制癌细胞的增殖，因此，可以有效地用作预防或治疗癌症的药物组合物。
• TRI-SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORS
  申请人：Kawanishi Eiji

  公开号：US20110160206A1

  公开（公告）日：2011-06-30

  The present invention provides a tri-substituted pyrimidine compound having an excellent PDE10 inhibitory activity. The present invention relates to a tri-substituted pyrimidine compound represented by the following formula [I 0 ] or a pharmaceutically acceptable salt thereof, a method for preparing the same, and use of said compound for PDE10 inhibitor, and a pharmaceutical composition comprising said compounds as an active ingredient: wherein: either one of X 1 and X 2 is N, and the other of X 1 and X 2 is CH; A is *-CH═CH—, *-C(Alk)=CH—, *-CH 2 —CH 2 — or *-O—CH 2 — (* is a bond with R 1 ); Alk is a lower alkyl group; Ring B is an optionally substituted nitrogen-containing aliphatic heterocyclic group; R 1 is an optionally substituted quinoxalinyl or an optionally substituted quinolyl; Y 0 is mono- or di-substituted amino group, or a pharmaceutically acceptable salt thereof.

  本发明提供了一种具有优异的PDE10抑制活性的三取代嘧啶化合物。本发明涉及一种由以下式[I0]表示的三取代嘧啶化合物或其药学上可接受的盐，以及制备该化合物的方法，以及将所述化合物用作PDE10抑制剂的用途，以及包含所述化合物作为活性成分的药物组合物：其中：X1和X2中的任一者为N，另一者为CH；A为*-CH═CH—，*-C(Alk)=CH—，*-CH2—CH2—或*-O—CH2—（*是与R1形成键）；Alk为较低的烷基基团；环B为可选择地取代的含氮脂肪杂环基团；R1为可选择地取代的喹唑啉基或可选择地取代的喝啉基；Y0为单取代或双取代的氨基团，或其药学上可接受的盐。